SI-B036

DRUG6 trials

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Breast CancerGastrointestinal TumorGynecological TumorsHead and Neck TumorsSolid CancerSolid TumorSolid TumorsUrological Cancer

Phase 1

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

RecruitingNCT07606612

Sichuan Baili Pharmaceutical Co., Ltd.Solid Tumor

Start: 2026-06-11End: 2028-12-01Target: 31Updated: 2026-06-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

RecruitingNCT07678970

Sichuan Baili Pharmaceutical Co., Ltd.Gastrointestinal Tumor, Solid Tumor

Start: 2026-07-30End: 2028-12-01Target: 10Updated: 2026-09-04

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Not yet recruitingNCT07744243

Sichuan Baili Pharmaceutical Co., Ltd.Solid Cancer, Urological Cancer

Start: 2026-08-01End: 2028-12-01Target: 30Updated: 2026-08-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

RecruitingNCT07753226

Sichuan Baili Pharmaceutical Co., Ltd.Breast Cancer, Solid Tumor

Start: 2026-08-18End: 2028-12-01Target: 39Updated: 2026-09-10

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors

Not yet recruitingNCT07763639

Sichuan Baili Pharmaceutical Co., Ltd.Head and Neck Tumors, Solid Tumors

Start: 2026-08-01End: 2028-12-01Target: 30Updated: 2026-08-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors

Not yet recruitingNCT07778862

Sichuan Baili Pharmaceutical Co., Ltd.Gynecological Tumors, Solid Tumors

Start: 2026-09-01End: 2028-12-01Target: 30Updated: 2026-08-26